ÂÜÀòÂÒÂ×

Alex Gutteridge is a seasoned professional in the field of bioinformatics and computational biology, currently serving as Vice President of Computational Biology at Novo Nordisk. Previous roles include Head of Bioinformatics at Dunad Therapeutics and Founder & Chief Scientific Officer at Enedra Therapeutics. Alex has also held the position of Head of Bioinformatics & Data Science at Lonza and served as Director at GSK. Academic credentials include a Doctor of Philosophy in Bioinformatics from the University of Cambridge, obtained between 2002 and 2005, and a Master of Business Administration in Business Administration and Management from the University of Cambridge, completed in May 2021.